Utah Medical Products - 20 Year Stock Price History | UTMD

Historical daily share price chart and data for Utah Medical Products since 1999 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Utah Medical Products as of January 18, 2019 is 86.32.
Utah Medical Products Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 84.6815 84.7700 86.4900 83.2200 86.3200 3.90%
2018 94.2264 78.8709 116.0000 74.6400 83.0800 2.62%
2017 68.7908 69.9530 83.5952 57.6573 80.9595 13.59%
2016 61.2251 56.5458 71.2756 53.5093 71.2756 26.31%
2015 53.9313 54.7851 59.5905 48.3410 56.4301 -0.72%
2014 49.6380 48.0860 56.9148 43.9436 56.8391 7.04%
2013 45.8990 34.8988 58.6409 34.8988 53.1027 61.74%
2012 29.2732 24.1608 32.9316 23.8689 32.8314 37.45%
2011 23.2622 23.0418 25.2375 21.3071 23.8866 4.07%
2010 22.3982 23.7884 24.9763 20.0103 22.9521 -2.73%
2009 20.6085 18.6019 23.9518 16.5613 23.5953 38.40%
2008 21.0796 22.2226 23.1986 16.4326 17.0485 -23.59%
2007 23.4762 24.0872 25.3360 21.9255 22.3127 -7.31%
2006 22.7389 21.7947 25.0252 20.2990 24.0726 5.78%
2005 16.6458 15.4089 22.7562 13.9450 22.7562 45.97%
2004 15.8116 17.4780 18.4608 11.8012 15.5893 -12.27%
2003 14.3944 13.1272 17.7703 11.8967 17.7703 36.86%
2002 10.6522 8.9735 13.1068 8.5248 12.9844 40.34%
2001 7.1521 5.0986 9.3406 4.7798 9.2522 81.47%
2000 4.8768 4.3780 5.6934 4.0789 5.0986 11.11%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.322B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $125.437B 25.42
Medtronic (MDT) Ireland $117.248B 17.53
Stryker (SYK) United States $62.695B 23.63
Boston Scientific (BSX) United States $52.155B 26.36
Baxter (BAX) United States $37.585B 24.27
Zimmer Biomet Holdings (ZBH) United States $21.487B 13.93
ResMed (RMD) United States $16.792B 32.02
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
Canopy Growth (CGC) Canada $10.104B 0.00
Bio-Rad Laboratories (BIO) United States $7.180B 45.91
Hill-Rom Holdings (HRC) United States $6.608B 20.68
Aurora Cannabis (ACB) Canada $6.428B 33.90
Perrigo (PRGO) Ireland $6.245B 9.48
Haemonetics (HAE) United States $5.216B 45.87
ICU Medical (ICUI) United States $4.878B 27.18
Insulet (PODD) United States $4.428B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.141B 0.00
Agios Pharmaceuticals (AGIO) United States $3.252B 0.00
Neogen (NEOG) United States $3.150B 48.38
Hutchison China MediTech (HCM) China $2.945B 0.00
National Vision Holdings (EYE) United States $2.566B 49.63
NuVasive (NUVA) United States $2.469B 22.98
Quidel (QDEL) United States $2.084B 27.17
NxStage Medical (NXTM) United States $1.901B 0.00
Aphria (APHA) $1.668B 74.22
Phibro Animal Health (PAHC) United States $1.294B 18.32
AtriCure (ATRC) United States $1.222B 0.00
VAREX IMAGING (VREX) United States $1.060B 21.23
Cardiovascular Systems (CSII) United States $1.013B 1457.00
PetIQ (PETQ) United States $0.781B 20.25
Cerus (CERS) United States $0.771B 0.00
OraSure Technologies (OSUR) United States $0.747B 42.03
Meridian Bioscience (VIVO) United States $0.713B 22.73
Eagle Pharmaceuticals (EGRX) United States $0.662B 21.24
Omeros (OMER) United States $0.658B 0.00
Surmodics (SRDX) United States $0.642B 97.18
Lantheus Holdings (LNTH) United States $0.637B 19.73
NanoString Technologies (NSTG) United States $0.624B 0.00
MacroGenics (MGNX) United States $0.520B 0.00
Quanterix (QTRX) United States $0.467B 0.00
LeMaitre Vascular (LMAT) United States $0.458B 22.48
Owens & Minor (OMI) United States $0.453B 5.12
Evolus (EOLS) United States $0.436B 0.00
TG Therapeutics (TGTX) United States $0.375B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.279B 0.00
Bovie Medical (APYX) United States $0.278B 0.00
Vapotherm (VAPO) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.244B 0.00
BioLife Solutions (BLFS) United States $0.226B 305.00
Rockwell Medical (RMTI) United States $0.198B 0.00
Fonar (FONR) United States $0.139B 7.00
Chimerix (CMRX) United States $0.137B 0.00
Surface Oncology (SURF) United States $0.136B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
United-Guardian (UG) United States $0.090B 18.85
Female Health (VERU) United States $0.084B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 18.07
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00